Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry
- PMID: 24329781
- DOI: 10.1111/his.12349
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry
Abstract
Aims: To assess the variation in ovarian carcinoma type diagnosis among gynaecological pathologists from Nordic countries, and whether a rationally designed panel of immunohistochemical markers could improve diagnostic reproducibility.
Methods and results: Eight pathologists from four countries (Sweden, Denmark, Norway, and Finland) received an educational lecture on the diagnosis of ovarian carcinoma type. All tumour-containing slides from 54 ovarian carcinoma cases were independently reviewed by the participants, who: (i) determined type purely on the basis of histology; (ii) indicated whether they would apply immunohistochemistry in their routine practice; and (iii) determined type after reviewing the staining results. The results for six markers (WT1, p53, p16, HNF-1β, ARID1A, and progesterone receptor) were determined for all 54 cases, by staining of a tissue microarray. The median concordance with central review diagnosis was 86%, and significantly improved to 90% with the incorporation of immunostaining results (P = 0.0002). The median interobserver agreement was 78%, and significantly improved to 85% with the incorporation of immunostaining results (P = 0.0002).
Conclusions: Use of the immunostaining results significantly improved both diagnostic accuracy and interobserver agreement. These results indicate that ovarian carcinoma type can be reliably diagnosed by pathologists from different countries, and also demonstrate that immunohistochemistry has an important role in improving diagnostic accuracy and agreement between pathologists.
Keywords: clear cell adenocarcinoma; cystic neoplasm; endometrioid carcinoma; mucinous neoplasm; ovary; reproducibility of results; serous neoplasm.
© 2013 John Wiley & Sons Ltd.
Similar articles
-
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7. Hum Pathol. 2008. PMID: 18602670
-
Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.Am J Surg Pathol. 2010 Jul;34(7):984-93. doi: 10.1097/PAS.0b013e3181e1a3bb. Am J Surg Pathol. 2010. PMID: 20505499
-
Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7. Am J Surg Pathol. 2008. PMID: 18460981
-
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Pathology. 2011. PMID: 21716157 Review.
-
Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms.J Clin Pathol. 2012 Jul;65(7):596-600. doi: 10.1136/jcp.2010.085688. Epub 2011 Jul 18. J Clin Pathol. 2012. PMID: 21768188 Review.
Cited by
-
Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.Int J Gynecol Pathol. 2019 Jul;38(4):353-362. doi: 10.1097/PGP.0000000000000530. Int J Gynecol Pathol. 2019. PMID: 29901523 Free PMC article.
-
Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.Gynecol Oncol. 2018 Sep;150(3):521-526. doi: 10.1016/j.ygyno.2018.07.003. Epub 2018 Jul 9. Gynecol Oncol. 2018. PMID: 30001835 Free PMC article.
-
A Clinical and Immunopathological Analysis of Carcinoma of the Ovary with an Emphasis on Post-chemotherapy Histopathologic Changes.Indian J Surg Oncol. 2023 Sep;14(3):545-552. doi: 10.1007/s13193-023-01756-2. Epub 2023 May 10. Indian J Surg Oncol. 2023. PMID: 37900629 Free PMC article.
-
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S40-S63. doi: 10.1097/PGP.0000000000000491. Int J Gynecol Pathol. 2019. PMID: 30550483 Free PMC article. Review.
-
Klotho promoter methylation status and its prognostic value in ovarian cancer.Mol Clin Oncol. 2021 Sep;15(3):181. doi: 10.3892/mco.2021.2343. Epub 2021 Jul 3. Mol Clin Oncol. 2021. PMID: 34277000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous